世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033507

依存症治療薬の世界市場(2023-2027)

TechNavio

Global Addictions Therapeutics Market 2023-2027

発刊日 2022/10/14

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000033507

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、依存症治療薬市場を分析します。

世界の依存症治療薬市場は、予測期間中に約7.65 %のCAGRで推移し、2023年から2027年の間に98億6,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、アルコール、タバコ、オピオイド製品の高い消費量、依存症治療のための新薬の承認やデジタル治療薬の発売、依存症に対する意識の向上と対策に向けた取り組みによって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ その他
    ➣ タイプ別
      ◇ アルコール依存症治療薬
      ◇ タバコ依存症治療薬
      ◇ 薬物依存症治療薬
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、新薬の研究開発の増加が、今後数年間の依存症治療薬市場の成長を促進する主要な理由の1つであると位置付けています。また、国が運営する無料の依存症治療プログラムや施設の出現、女性のアルコール消費量の増加は、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 依存症治療薬の市場規模
  • 依存症治療薬の市場予測
  • 依存症治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な依存症治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Alkermes Public Ltd. Co.
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Aphios Corp.
    ➣ Braeburn Inc.
    ➣ Emergent BioSolutions Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Glenmark Pharmaceuticals Ltd.
    ➣ Hikma Pharmaceuticals Plc
    ➣ Indivior Plc
    ➣ Johnson and Johnson
    ➣ kaleo Inc
    ➣ Mallinckrodt Plc
    ➣ Orexo AB
    ➣ 大塚ホールディングス(Otsuka Holdings Co. Ltd.)
    ➣ Pfizer Inc.
    ➣ Purdue Pharma LP
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Titan Pharmaceuticals Inc., and
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by Distribution Channel
5.1 Market segments
Exhibit 25: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 26: Data Table on Distribution Channel - Market share 2022-2027 (%)
5.2 Comparison by Distribution Channel
Exhibit 27: Chart on Comparison by Distribution Channel
Exhibit 28: Data Table on Comparison by Distribution Channel
5.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 29: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 30: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 31: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
5.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 33: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 34: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
5.5 Others - Market size and forecast 2022-2027
Exhibit 37: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 38: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 40: Data Table on Others - Year-over-year growth 2022-2027 (%)
5.6 Market opportunity by Distribution Channel
Exhibit 41: Market opportunity by Distribution Channel ($ billion)

6 Market Segmentation by Type
6.1 Market segments
Exhibit 42: Chart on Type - Market share 2022-2027 (%)
Exhibit 43: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 44: Chart on Comparison by Type
Exhibit 45: Data Table on Comparison by Type
6.3 Alcohol addiction therapeutics - Market size and forecast 2022-2027
Exhibit 46: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.4 Tobacco addiction therapeutics - Market size and forecast 2022-2027
Exhibit 50: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.5 Drug addiction therapeutics - Market size and forecast 2022-2027
Exhibit 54: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 55: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 57: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 58: Market opportunity by Type ($ billion)

7 Customer Landscape
7.1 Customer landscape overview
Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Exhibit 60: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 61: Data Table on Market share By Geographical Landscape 2022-2027 (%)
8.2 Geographic comparison
Exhibit 62: Chart on Geographic comparison
Exhibit 63: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2022-2027
Exhibit 64: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on North America - Year-over-year growth 2022-2027 (%)
8.4 Europe - Market size and forecast 2022-2027
Exhibit 68: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Europe - Year-over-year growth 2022-2027 (%)
8.5 Asia - Market size and forecast 2022-2027
Exhibit 72: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Asia - Year-over-year growth 2022-2027 (%)
8.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
8.7 US - Market size and forecast 2022-2027
Exhibit 80: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 83: Data Table on US - Year-over-year growth 2022-2027 (%)
8.8 Germany - Market size and forecast 2022-2027
Exhibit 84: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 87: Data Table on Germany - Year-over-year growth 2022-2027 (%)
8.9 Canada - Market size and forecast 2022-2027
Exhibit 88: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 91: Data Table on Canada - Year-over-year growth 2022-2027 (%)
8.10 UK - Market size and forecast 2022-2027
Exhibit 92: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 95: Data Table on UK - Year-over-year growth 2022-2027 (%)
8.11 France - Market size and forecast 2022-2027
Exhibit 96: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 99: Data Table on France - Year-over-year growth 2022-2027 (%)
8.12 Market opportunity By Geographical Landscape
Exhibit 100: Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends

10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
10.4 Industry risks
Exhibit 104: Impact of key risks on business

11 Vendor Analysis
11.1 Vendors covered
Exhibit 105: Vendors covered
11.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
11.3 Alkermes Public Ltd. Co.
Exhibit 107: Alkermes Public Ltd. Co. - Overview
Exhibit 108: Alkermes Public Ltd. Co. - Product / Service
Exhibit 109: Alkermes Public Ltd. Co. - Key news
Exhibit 110: Alkermes Public Ltd. Co. - Key offerings
11.4 Amneal Pharmaceuticals Inc.
Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
11.5 Aphios Corp.
Exhibit 116: Aphios Corp. - Overview
Exhibit 117: Aphios Corp. - Product / Service
Exhibit 118: Aphios Corp. - Key offerings
11.6 Braeburn Inc.
Exhibit 119: Braeburn Inc. - Overview
Exhibit 120: Braeburn Inc. - Product / Service
Exhibit 121: Braeburn Inc. - Key offerings
11.7 Emergent BioSolutions Inc.
Exhibit 122: Emergent BioSolutions Inc. - Overview
Exhibit 123: Emergent BioSolutions Inc. - Product / Service
Exhibit 124: Emergent BioSolutions Inc. - Key news
Exhibit 125: Emergent BioSolutions Inc. - Key offerings
11.8 GlaxoSmithKline Plc
Exhibit 126: GlaxoSmithKline Plc - Overview
Exhibit 127: GlaxoSmithKline Plc - Business segments
Exhibit 128: GlaxoSmithKline Plc - Key offerings
Exhibit 129: GlaxoSmithKline Plc - Segment focus
11.9 Glenmark Pharmaceuticals Ltd.
Exhibit 130: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 131: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 132: Glenmark Pharmaceuticals Ltd. - Key offerings
11.10 Hikma Pharmaceuticals Plc
Exhibit 133: Hikma Pharmaceuticals Plc - Overview
Exhibit 134: Hikma Pharmaceuticals Plc - Business segments
Exhibit 135: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 136: Hikma Pharmaceuticals Plc - Segment focus
11.11 Indivior Plc
Exhibit 137: Indivior Plc - Overview
Exhibit 138: Indivior Plc - Product / Service
Exhibit 139: Indivior Plc - Key offerings
11.12 Mallinckrodt Plc
Exhibit 140: Mallinckrodt Plc - Overview
Exhibit 141: Mallinckrodt Plc - Business segments
Exhibit 142: Mallinckrodt Plc - Key news
Exhibit 143: Mallinckrodt Plc - Key offerings
Exhibit 144: Mallinckrodt Plc - Segment focus
11.13 Orexo AB
Exhibit 145: Orexo AB - Overview
Exhibit 146: Orexo AB - Product / Service
Exhibit 147: Orexo AB - Key offerings
11.14 Otsuka Holdings Co. Ltd.
Exhibit 148: Otsuka Holdings Co. Ltd. - Overview
Exhibit 149: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 150: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 151: Otsuka Holdings Co. Ltd. - Segment focus
11.15 Pfizer Inc.
Exhibit 152: Pfizer Inc. - Overview
Exhibit 153: Pfizer Inc. - Product / Service
Exhibit 154: Pfizer Inc. - Key news
Exhibit 155: Pfizer Inc. - Key offerings
11.16 Teva Pharmaceutical Industries Ltd.
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
11.17 Titan Pharmaceuticals Inc.
Exhibit 161: Titan Pharmaceuticals Inc. - Overview
Exhibit 162: Titan Pharmaceuticals Inc. - Product / Service
Exhibit 163: Titan Pharmaceuticals Inc. - Key offerings

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
12.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
12.5 List of abbreviations
Exhibit 170: List of abbreviations
health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global addictions therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Five forces analysis - Comparison between2022 and 2027
Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits25: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits26: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits27: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits28: Chart on Market condition - Five forces 2022 and 2027
Exhibits29: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits30: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Chart on Comparison by Distribution Channel
Exhibits32: Data Table on Comparison by Distribution Channel
Exhibits33: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits34: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits37: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits38: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits40: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits42: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits44: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Market opportunity by Distribution Channel ($ billion)
Exhibits46: Chart on Type - Market share 2022-2027 (%)
Exhibits47: Data Table on Type - Market share 2022-2027 (%)
Exhibits48: Chart on Comparison by Type
Exhibits49: Data Table on Comparison by Type
Exhibits50: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits54: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits55: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits56: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits57: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits58: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits59: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits60: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits61: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits62: Market opportunity by Type ($ billion)
Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits64: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Chart on Geographic comparison
Exhibits67: Data Table on Geographic comparison
Exhibits68: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits80: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits84: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits88: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits95: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits102: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits103: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits104: Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Alkermes Public Ltd. Co. - Overview
Exhibits112: Alkermes Public Ltd. Co. - Product / Service
Exhibits113: Alkermes Public Ltd. Co. - Key news
Exhibits114: Alkermes Public Ltd. Co. - Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. - Overview
Exhibits116: Amneal Pharmaceuticals Inc. - Business segments
Exhibits117: Amneal Pharmaceuticals Inc. - Key news
Exhibits118: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits119: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits120: Aphios Corp. - Overview
Exhibits121: Aphios Corp. - Product / Service
Exhibits122: Aphios Corp. - Key offerings
Exhibits123: Braeburn Inc. - Overview
Exhibits124: Braeburn Inc. - Product / Service
Exhibits125: Braeburn Inc. - Key offerings
Exhibits126: Emergent BioSolutions Inc. - Overview
Exhibits127: Emergent BioSolutions Inc. - Product / Service
Exhibits128: Emergent BioSolutions Inc. - Key news
Exhibits129: Emergent BioSolutions Inc. - Key offerings
Exhibits130: GlaxoSmithKline Plc - Overview
Exhibits131: GlaxoSmithKline Plc - Business segments
Exhibits132: GlaxoSmithKline Plc - Key offerings
Exhibits133: GlaxoSmithKline Plc - Segment focus
Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits137: Hikma Pharmaceuticals Plc - Overview
Exhibits138: Hikma Pharmaceuticals Plc - Business segments
Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits141: Indivior Plc - Overview
Exhibits142: Indivior Plc - Product / Service
Exhibits143: Indivior Plc - Key offerings
Exhibits144: Mallinckrodt Plc - Overview
Exhibits145: Mallinckrodt Plc - Business segments
Exhibits146: Mallinckrodt Plc - Key news
Exhibits147: Mallinckrodt Plc - Key offerings
Exhibits148: Mallinckrodt Plc - Segment focus
Exhibits149: Orexo AB - Overview
Exhibits150: Orexo AB - Product / Service
Exhibits151: Orexo AB - Key offerings
Exhibits152: Otsuka Holdings Co. Ltd. - Overview
Exhibits153: Otsuka Holdings Co. Ltd. - Business segments
Exhibits154: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits155: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits165: Titan Pharmaceuticals Inc. - Overview
Exhibits166: Titan Pharmaceuticals Inc. - Product / Service
Exhibits167: Titan Pharmaceuticals Inc. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

この商品のレポートナンバー

0000033507

TOP